Table 12.
Stable vs Con | AE-1 vs Con | AE-3 vs Con | AE-10 vs Con | ||||
---|---|---|---|---|---|---|---|
Fold changes | Genes | Fold changes | Genes | Fold changes | Genes | Fold changes | Genes |
10.7 | EIF3S6 | 10.3 | HAND1 | 10.2 | GZMK | 10.0 | C21orf7 |
10.7 | YLPM1 | 10.3 | CD8B | 10.5 | CXCR3 | 10.0 | NELL2 |
16.1 | TFCP2L1 | 10.4 | UBASH3A | 10.6 | AK5 | 10.4 | C21orf7 |
21.0 | SCP2 | 10.8 | TRA@ | 10.7 | TRA@ | 10.4 | GFI1B |
10.9 | TRBV3-1 | 10.7 | IL24 | 10.5 | LOC129293 | ||
11.2 | CD8B | 10.9 | CD6 | 10.5 | LOC123876 | ||
11.4 | MAL | 10.9 | N/A | 10.7 | HIST1H3H | ||
11.4 | LOC643514 | 11.2 | KIAA0748 | 11.1 | IL24 | ||
11.5 | NELL2 | 11.4 | LCK | 11.4 | GFI1B | ||
11.7 | TTC24 | 11.5 | CD8B | 11.9 | CRTAC1 | ||
12.7 | CD8B | 12.3 | APBB1 | 11.9 | OR10A4 | ||
13.1 | LEF1 | 12.3 | IL12RB1 | 11.9 | SAA3P | ||
13.8 | TCF7 | 12.5 | TTC24 | 12.7 | TTC24 | ||
14.2 | LOC129293 | 12.5 | GFI1B | 14.9 | TFCP2L1 | ||
14.5 | LOC129293 | 12.5 | CRTAC1 | 18.6 | SCP2 | ||
15.6 | TCF7 | 12.6 | TRBV3-1 | 32.3 | UNQ470 | ||
16.1 | TCF7 | 12.6 | ATG9B | ||||
16.8 | CD8B | 12.9 | ABLIM1 | ||||
21.8 | TFCP2L1 | 12.9 | LOC129293 | ||||
25.4 | CRTAC1 | 13.0 | CD8B | ||||
27.9 | SCP2 | 13.1 | CD28 | ||||
44.1 | UNQ470 | 13.1 | GRAP2 | ||||
14.3 | UBASH3A | ||||||
14.4 | CCR7 | ||||||
15.0 | LOC129293 | ||||||
16.0 | CD8B | ||||||
18.1 | UNQ470 | ||||||
18.7 | SCP2 | ||||||
18.8 | LEF1 | ||||||
19.3 | LEF1 | ||||||
23.5 | CD8B | ||||||
24.3 | TCF7 | ||||||
25.1 | TCF7 | ||||||
30.4 | TCF7 | ||||||
32.0 | TFCP2L1 |
aData are from patients with stable chronic obstructive pulmonary disease (Stable) or acute exacerbation of chronic obstructive pulmonary disease on day 1 (AE-1), day 3 (AE-3) and day 10 (AE-10) of the hospital admission, as compared to healthy controls (Con).